Search research articles
Contact Us
Filters
Showing results (111-120 of 134) with videos related to
Page
of 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 14, 2021
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials
Kristine M Erlandson, Christoph C Carter, Kathleen Melbourne, et al.
HIV Medicine
|
December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022
Laura Waters, Alan Winston, Iain Reeves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
HIV Medicine
|
December 17, 2020
British HIV Association/British Association for Sexual Health and HIV/British Infection Association adult HIV testing guidelines 2020
Adrian Palfreeman, Ann Sullivan, Michael Rayment, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
Abiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Laura Waters, Lambert Assoumou, Ana González-Cordón, et al.
PLOS Global Public Health
|
February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak
Vanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
José M Gatell, Lambert Assoumou, Graeme Moyle, et al.
AIDS (London, England)
|
April 2, 2019
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials
Samir K Gupta, Frank A Post, José R Arribas, et al.
Nature
|
March 6, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K Gupta, Sultan Abdul-Jawad, Laura E McCoy, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 134) with videos related to
Sort By:
Page
of 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 14, 2021
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials
Kristine M Erlandson, Christoph C Carter, Kathleen Melbourne, et al.
HIV Medicine
|
December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022
Laura Waters, Alan Winston, Iain Reeves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
HIV Medicine
|
December 17, 2020
British HIV Association/British Association for Sexual Health and HIV/British Infection Association adult HIV testing guidelines 2020
Adrian Palfreeman, Ann Sullivan, Michael Rayment, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
Abiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Laura Waters, Lambert Assoumou, Ana González-Cordón, et al.
PLOS Global Public Health
|
February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak
Vanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
José M Gatell, Lambert Assoumou, Graeme Moyle, et al.
AIDS (London, England)
|
April 2, 2019
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials
Samir K Gupta, Frank A Post, José R Arribas, et al.
Nature
|
March 6, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K Gupta, Sultan Abdul-Jawad, Laura E McCoy, et al.
Page
of 14